University of Vermont

UVM ScholarWorks
Graduate College Dissertations and Theses

Dissertations and Theses

2022

Building a Learning Healthcare System: a path to optimizing big
health data to inform clinical care decisions
Danne Charlotte Emily Elbers
University of Vermont

Follow this and additional works at: https://scholarworks.uvm.edu/graddis
Part of the Bioinformatics Commons, Computer Sciences Commons, and the Medical Sciences
Commons

Recommended Citation
Elbers, Danne Charlotte Emily, "Building a Learning Healthcare System: a path to optimizing big health
data to inform clinical care decisions" (2022). Graduate College Dissertations and Theses. 1550.
https://scholarworks.uvm.edu/graddis/1550

This Dissertation is brought to you for free and open access by the Dissertations and Theses at UVM
ScholarWorks. It has been accepted for inclusion in Graduate College Dissertations and Theses by an authorized
administrator of UVM ScholarWorks. For more information, please contact scholarworks@uvm.edu.

Building a Learning Healthcare
System: a path to optimizing big health
data to inform clinical care decisions
A Dissertation Presented

by
Danne Charlotte Emily Pieneman - Elbers
to
The Faculty of the Graduate College
of
The University of Vermont

In Partial Fulfillment of the Requirements
for the Degree of Doctor of Philosophy
Specializing in Complex Systems and Data Science
May, 2022

Defense Date: March 23rd, 2022
Dissertation Examination Committee:
Peter Dodds, Ph.D., Advisor
Chris Danforth, Ph.D., Advisor
Sarah A. Nowak, Ph.D., Chairperson
Robert E. Gramling, M.D., D.Sc.
Safwan Wshah, Ph.D.
Cynthia J. Forehand, Ph.D., Dean of the Graduate College

Abstract

The explosive growth of data and computing power of the last decades has had large
impacts on a myriad of domains, not in the least on one of society’s most complex
systems: healthcare. In this work, a version of the resulting Learning Healthcare
System (LHS) is explored and elements of it have been implemented and are in use at
the Department of Veterans’ Affairs today. After an overview of what a LHS is and
what it could be once executed in its full form, the chapters will describe in detail some
of the individual elements and how they address cogs of the LHS’ cyclic system. A
data repository and clinical knowledge base to facilitate the LHS, called the Precision
Oncology Data Repository (PODR), will be highlighted, as will two applications:
one addressing clinical trial enrollment at point of care, and another synchronization
data back into the clinics and hospitals at the (on-going) time of the COVID-19
epidemic. Both these applications are heavily utilizing the large Electronic Health
Record real-world data to generate actionable knowledge while applying advanced
analytics. Lastly, this thesis presents a methodology for re-calibrating and validating
sentiment analysis of EHR clinical notes to facilitate a near real-time pulse of the
interaction between patients, providers and the hospital, with the goal of delivering
new insights and allowing for iterative adaption based on measurable performance.
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Chapter 1
Introduction

1

1.1
1.1.1

Background
Historic view of the Electronic Healthcare Record System

The evolution in medical record keeping through creating an electronic health record
system (EHR) started near the end of the ’60s in the United States, with the Massachusetts General Hospital (MGH) being the first adopter utilizing the Computer
Stored Ambulatory Record (COSTAR) system, which was developed in collaboration
with Harvard (Barnett et al., 1979). MGH’s implementation was quickly followed
by the Department of Veterans Affairs’ (VA) adoption and nationwide roll out of
the VA health information system and technology architecture, commonly known as
VistA, during the ’70s till mid ’80s (Atherton, 2011)(Brown, 2003)(Olsen, Aisner, &
McGinnis, 2007).
Originally developed for billing purposes, improving the standards of clinical care
through better record keeping and an increase in quality assurance and improvement
capabilities (Hersh, 2007)(I. o. M., 2003)(Bates et al., 1999), the roll out of EHRs
signified the start of a multitude of new health research areas. It didn’t take long
for the first research projects were proposed taking advantage of this new wealth of
data, and secondary data use became adopted within medical research. Since then,
EHRs all over the world have been initiated, implemented in clinics and hospitals,
and continue to grown in size and types of data they support (Wen, Ho, Jian, Li, &
Hsu, 2007)(Casey, Schwartz, Stewart, & Adler, 2016). Today, at the VA alone, the
EHR data systems have expanded to supporting over 1.5 petabyte of data.
2

1.1.2

Healthcare Data Science and Complex Systems Research

In addition to its ongoing growth in volume, healthcare data has grown substantially
in complexity due to its utilization, ever-expanding treatment pathways, and addition
of new techniques generating new data types (Greenhalgh & Papoutsi, 2018)(Burton,
Elliott, Cochran, & Love, 2018). Nowadays a patient encounter with a given medical
center can generate a large set of diverse data elements for example; clinical data,
imaging scans (MRI, PT, CT), all sorts of genomic sequencing results, pathology tissue and digital pathology slide scans. Data types range from: standard elements such
as structured and unstructured text, date-time stamps, Clinical Modification Diagnoses (ICD-9-CM and ICD-10-CM) and prescription (Rx) codes housed in large data
warehouses, to Digital Imaging and Communication in Medicine (DICOMs)(Mustra,
Delac, & Grgic, 2008), FASTQs, PDFs, VCFs and BAMs, and the list doesn’t end
there.
It is not surprising that researchers jumped in enthusiastically to make, secondary or
primary, use of this plethora of healthcare data. For example, in population research
and epidemiology, large-scale studies have taken advantage of secondary data use,
creating research cohorts that easily range over >10.000 patients (Casey et al., 2016).
While in the Natural Language Processing domain of Machine Learning work has been
done building algorithms to extract information from clinical notes (Sheikhalishahi
et al., 2019)(Alba et al., 2021)(Meng, Morioka, & Elbers, 2019). Machine learning
approaches and data science research in healthcare has taken off in general (Ghassemi
et al., 2020)(Ben-Israel et al., 2020), even so much so that the VA recently started
3

their own Artificial Intelligence Institute (HealthITAnalytics, 2019).

1.1.3

Gap between Research and Clinical Implementation

Idealistically, the goal of healthcare related research is to improve patient outcomes
and the quality of care patients receive. Unfortunately, it can take years for any
given research outcome to make it back into the clinic (Morris, Wooding, & Grant,
2011)(Budrionis & Bellika, 2016). This is often called the ’bench to bedside’ gap
and exists both in the traditional clinical trial type research as it does in the newer
translational and, machine learning or data science research approaches (Ben-Israel
et al., 2020)(van der Laan & Boenink, 2015). The gap between research outcomes
and clinical implementation and/or adoption can be attributed to several causes. In
the domain of traditional clinical trial type research, it takes time to validate new
findings and embed them into current clinical standards and practice. Whereas in machine learning and data science, transparency of the algorithms and delivery of them
back into the clinic are often named as obstacles (Ben-Israel et al., 2020)(Hakkoum,
Abnane, & Idri, 2022).

4

1.2
1.2.1

The Learning Healthcare System
Definition

In 2006, the Institute of Medicine held a round-table conference to address the issue
outlined above and introduced and defined the Learning Healthcare System (LHS)
as: "A learning healthcare system is one that is designed to generate and apply the
best evidence for the collaborative healthcare choices of each patient and provider;
to drive the process of discovery as a natural outgrowth of patient care; and to
ensure innovation, quality, safety, and value in health care". (Olsen et al., 2007)
Unlike research efforts with traditional clinical trials where the emphasis is on the
population under ideal conditions, LHS’s attention is on treatment and interventions
that are optimized for the patients under real world conditions.

1.2.2

Components

Multiple models for implementation of a LHS have been proposed to meet the mandate issued by the Institute of Medicine to transform healthcare systems. Inherent to
all of them are three essential infrastructure-related activities supporting a learning
cycle. These are
(A) the creation of clinical knowledge bases to integrate and manage a growing volume and variety of data,
(B) the generation of actionable knowledge using real-world evidence and advanced
analytics and,
(C) the delivery and application of these newly discovered insights (knowledge) to
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improve patient care as well as the iterative adaptation based on performance.
Each of these three core activities encompasses multiple informatics approaches and
technological challenges. In the learning cycle described by Friedman et al. (Friedman,
Rubin, & Sullivan, 2017) there is often a disconnect or gap between the research activities that generate the knowledge from data and the clinical operational activities
of implementing knowledge to improve performance, as outlined above. This work
highlights three publications on multiple projects that are underway to inform not
only the technology but the people, policy, and processes necessary to integrate both
research and clinical activities for continuous iterations of learning.
Since 2007, numerous LHS models have been described, each encompassing and building on the three core tasks described above. In their LHS review, McLachlan et al.
(McLachlan et al., 2018) noted a general lack of consistency in the description of
most LHS efforts and proposed a taxonomy which decomposes the three core tasks
into nine primary archetypes of which six rely on cohort identification. The LHS taxonomy has been further advanced by Wouters et al. (Wouters, van der Graaf, Voest,
& Bredenoord, 2020) who described four LHS implementation models (Optimization
LHS, Comprehensive Data LHS, Real time LHS, Full LHS). A Full LHS implementation model has workflow components that optimize the analysis of observational data,
deliver real time actionable knowledge through clinical decision support, and inform
treatment decision through embedded clinical trials. The following chapter (chapter
2) describes the development and implementation of an application (ProjectFlow),
that successfully embeds clinical trials into the clinical care workflow to facilitate national point-of-care research (Dhond et al., 2021).
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Subsequently in chapter 3 the generation of a knowledge repository, the Precision Oncology Data Repository (PODR)(Elbers et al., 2020), is addressed fulfilling
element (A) of a LHS described by Friedman et al. Both of these chapters relate
to an LHS system specifically in oncology, a healthcare domain highlighted as very
well suited for this purpose (Do et al., 2019). The proposed bigger, and partially
implemented, picture for a LHS in oncology at the VA can be seen in figure 1.1.
In chapter 5, research is described re-calibrating and applying a social-science sentiment measurement instrument, the Hedonometer, (Dodds, Harris, Kloumann, Bliss,
& Danforth, 2011) to clinical oncology notes, in order to better understand the interaction between patient, provider and healthcare system (Elbers et al., 2022). This
allows for the execution of the ’Generated Knowledge & Algorithms’ loop in figure
1.1 and item (B) according to Friedman’s LHS description. Friedman’s item (C), can
be partially found in chapter 2 mentioned above, but is also addressed in chapter
4 through an application developed to assist the VA Boston during the start of the
COVID-19 epidemic. This framework has subsequently been reused in the oncology
LHS and deployed as a application platform housing a clinical trial matching and
tumor-board app (manuscript in development). This last piece completes the full
circle of a LHS as described above, though its implementation is lean at the moment.
Over the upcoming years, the LHS will benefit from the addition of many components and constant tweaking and tailoring to ensure a continuous optimization of
data, enabling clinical care decisions.
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Figure 1.1: Precision Oncology Learning Healthcare System; flowchart diagram shows the
partially implemented, partially planned lay-out of a LHS in oncology at the department of
Veterans Affairs.
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Chapter 2
ProjectFlow: a configurable workflow management application for
point of care research
This Chapter is derived from Dhond & Elbers et al. (Dhond et al., 2021)

9

2.1

Abstract

Objective: To best meet our point-of-care research (POC-R) needs, we developed
ProjectFlow, a configurable, clinical research workflow management application. In
this article, we describe ProjectFlow and how it is used to manage study processes
for the Diuretic Comparison Project (DCP) and the Research Precision Oncology
Program (RePOP).
Materials and methods: The Veterans Health Administration (VHA) is the largest integrated health care system in the United States. ProjectFlow is a flexible web-based
workflow management tool specifically created to facilitate conduct of our clinical
research initiatives within the VHA. The application was developed using the Grails
web framework and allows researchers to create custom workflows using Business Process Model and Notation.
Results: As of January 2021, ProjectFlow has facilitated management of study recruitment, enrollment, randomization, and drug orders for over 10 000 patients for
the DCP clinical trial. It has also helped us evaluate over 3800 patients for recruitment and enroll over 370 of them into RePOP for use in data sharing partnerships
and predictive analytics aimed at optimizing cancer treatment in the VHA.
Discussion: The POC-R study design embeds research processes within day-to-day
clinical care and leverages longitudinal electronic health record (EHR) data for study
recruitment, monitoring, and outcome reporting. Software that allows flexibility in
study workflow creation and integrates with enterprise EHR systems is critical to the
success of POC-R. Conclusions: We developed a flexible web-based informatics solution called ProjectFlow that supports custom research workflow configuration and
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has ability to integrate data from existing VHA EHR systems.

2.2

Introduction

The Veterans Health Administration (VHA) is the largest integrated health care system in the United States, providing care for over 9 million Veterans at over 1255
facilities across the nation(V. H. A., n.d.). Over the past decade, the VA Office of
Research and Development (VA ORD) has supported the implementation of pointof-care research (POC-R)(Point of Care Research (POC-R), n.d.) with an emphasis
on point-of-care clinical trials (POCCT), that is pragmatic clinical trials(Loudon et
al., 2015) that compare approved treatment options when clinicians are in equipoise.
The POC-R design aims to embed research workflows within day-to-day clinical operations with minimal interference to care, thereby allowing study endpoints, treatment
deviations, and patient compliance data to be extracted from a patient’s longitudinal
electronic health record (EHR). POC-R also leverages EHR data for study recruitment. This clinically embedded design is advantageous in reducing research costs and
promoting realization of a learning healthcare system by facilitating the translation of
research evidence into clinical practice(Staa et al., 2012)(Vickers & Scardino, 2009).
Workflow management software that can accommodate complex POC-R workflows
while also integrating with enterprise EHR infrastructures is crucial to the success of
point-of-care initiatives. Although numerous software options exist, many out-of-thebox tools lack flexibility(Nourani, Ayatollahi, & Dodaran, 2019), forcing researchers
to either sacrifice integration with EHR systems or substantially modify their preferred study workflows. Within the VHA, software selection is further complicated
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by requirements for compliance with robust data security rules as well as integration
with its mature and rigid EHR infrastructures. Indeed, formal VHA approval for the
installation and use of commercial or open source tools with protected health data
may take years.
We developed a flexible web-based informatics solution called ProjectFlow that supports custom research workflow configuration and has ability to integrate data from
existing VHA EHR systems. In this article, we describe how ProjectFlow is used to
support a range of research study processes, from a focused patient enrollment process into a national data repository to the multiple complex processes of a multicenter
POCCT.

2.2.1

Research Precision Oncology Program

Research Precision Oncology Program (RePOP) is the research component of the
national clinical program named the Precision Oncology Program (POP). RePOP
recruits and enrolls patients interested in sharing their de-identified electronic health
data with the Precision Oncology Data Repository (PODR) for the purpose of innovating VHA cancer treatment(Do et al., 2019)(Elbers et al., 2020). This includes,
but is not limited to, building genomic-based outcome prediction engines for clinical
decision support. Cancer is a multifaceted disease, requiring an enormous amount
of aggregate data to develop generalizable findings. To this extent PODR acquires
patient genomic, clinical health, and medical image data (eg, radiological, pathological, and others). At present, RePOP utilizes ProjectFlow to support the contact and
enrollment of eligible patients.
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2.2.2

Diuretic Comparison Project

Diuretic Comparison Project (DCP) is a POCCT which evaluates the relative effectiveness of two widely prescribed thiazide-diuretics used in the treatment of hypertension. Specifically, the VHA national outpatient prescription database shows that over
a million veterans were prescribed a thiazide-type diuretic each year from 2003 to 2008
with over 95% receiving hydrochlorothiazide (HCTZ) and less than 2.5% receiving
chlorthalidone (CTD).(Ernst & Lund, 2010) However, recent evidence suggests CTD
may not only be more effective for managing symptoms but also less expensive(Ernst
& Lund, 2010). To better understand the relative effectiveness of these medications,
the DCP trial compares cardiovascular outcomes in patients treated with HCTZ versus CTD. At present, DCP is actively enrolling patients and utilizing the ProjectFlow
application to support trial recruitment, consent, randomization, and prescription order monitoring.

2.3
2.3.1

Materials and Methods
Key ProjectFlow functionalities

Customizable workflows and role-based access control
ProjectFlow is a flexible web-based workflow management tool created to facilitate
the conduct of national POC-R within the VHA. ProjectFlow allows researchers to
create custom workflows using the standards-based Business Process Model and Notation (BPMN, version 2.0). BPMN employs graphical elements as representations
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of business processes(Ko, Lee, & Wah Lee, 2009)(White & Bock, 2011). Researchers
may generate their study-specific workflows using the Eclipse IDE (Burnette, n.d.)
and Activiti plugins(Activiti, 2022). ProjectFlow was developed using the Grails
web framework. Previously known as "Groovy on Rails," Grails is an open source
web application framework which uses Apache Groovy, a Java syntax compatible
language(Judd, Nusairat, & Shingler, 2008). ProjectFlow also employs "plug-andplay" web-services to ensure smooth integration with EHR databases through synchronous (immediate response) or asynchronous (delayed re- sponse) communication.
When creating POC-R workflows, ProjectFlow users first define "clinical elements."
A clinical element is an object with specified properties that may move through a
workflow. For example, a clinical element could be a physician, patient, medication,
genomic sample or even a hospital location. Using BPMN 2.0 notation, users may
design simple or complex workflows that a clinical element may move through (Figure
2.1A). The creation of study-specific workflows requires a general understanding of
workflow notation as well as a moderate to strong understanding of database structures and relevant EHR data fields. Furthermore, a clear understanding of studyspecific clinical processes is essential. Although initially a steep learning curve, we
have found that staff members with sufficient training are able to contribute to complex workflow development within a few hours.
ProjectFlow employs Role-Based Access Control (RBAC) to manage how its users interact with clinical elements and workflows. RBAC allows control over which data a
user (role) may access as well as the scope of functions (tasks) each role may perform.
To keep patients’ personally identifiable information secure, a study may restrict
access to certain data elements depending on the role or expand access as the role
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changes.

Integration with enterprise EHR systems
As noted previously, POC-R utilizes longitudinal EHR data for pa- tient recruitment and monitoring. ProjectFlow databases query VHA EHR systems regularly to
obtain recent relevant data. The Vet- erans Health Information Systems and Technology Architecture (VistA), developed in 1999, serves as the backbone of the VHAâs
EHR(Brown, 2003) until the transition to the Cerner EHR (fully operational by 2028)
is complete. Clinicians access and enter patient data into VistA via the Computerized
Patient Record System (CPRS) user in- terface. VistA data is transferred nightly
to the VA Corporate Data Warehouse (CDW) where it resides in Microsoft SQL
(MSSQL) databases for secondary use. Access to CDW data for research is managed
by the VA Informatics and Computing Infrastructure (VINCI). To facilitate access
to CDW systems the ProjectFlow appli- cation is hosted on virtual machines (VMs)
within the VINCI envi- ronment. A generalized depiction of data flow for the ProjectFlow system is shown in Figure 2.1B.
Similar to our groupâs insulin POCCT pilot(D’Avolio et al., 2012)(L. D. Fiore et al.,
2011) we have further leveraged VHA EHR functionalities through the use of modified CPRS/VistA interfaces. However, this time we have applied modifications on a
national level as opposed to just a single VHA site. To provide a specific example,
the DCP study utilizes CPRS "View Alerts" to facilitate provider consent to patient
enrollment and randomization (Figure 2.2). As these alerts are embedded within the
CPRS interface, the data entered within them becomes part of the patient’s longitudinal health record and the official system of record.
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Figure 2.1: Workflow creation
and integration with VHA EHR
systems. (A) Example of simple BPMN 2.0 workflow: User
defined clinical elements proceed through user designed study
workflows. The figure depicts
a workflow for updating a patient’s status.
More specifically, once the "Update Patient
Status" task is completed, synchronous web-service communication transmits the updated information to the database. If
an error occurs in transmission,
this will be registered via the "IT
logâ pathway. (B) Data flow
utilized by the ProjectFlow webbased application: (B1) Clinicians utilize the computerized
patient record system (CPRS)
user interface to access and
enter patient data into VistA.
The DCP study utilizes "View
Alerts" embedded within CPRS
to facilitate trial recruitment,
randomization, and prescription
ordering.
(B2) VistA data
are transferred nightly to the
VA Corporate Data Warehouse
(CDW) where it resides for secondary operational and research
use. (B3) Scheduled, nightly,
extract transform load processes
extract relevant EHR data from
CDW into the study database
(Study DB) which is utilized by
(B4) ProjectFlow as needed for
patient recruitment, randomization, prescription tracking and
monitoring. Authorized study
staff may access the ProjectFlow system and CPRS via their
VHA workstation.
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Figure 2.2: Integration with clinical interfaces, CPRS view alerts. (A) DCP utilizes CPRS
"View Alert" screens to obtain provider consent to contact a patient (top panel) and (B)
obtain provider consent to randomize consented patients (bottom panel). Providers may
"Discontinue" or "Sign" these requests (red arrows). As the view alerts are embedded in
CPRS the provider response also becomes part of the patient record. ProjectFlow queries
and tracks these provider responses as they appear within the CDW.
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ProjectFlow user dashboards and assigned task prioritization
Users interact with ProjectFlow by navigating within their dash- board (Figure 2.3).
For example, Figure 3A shows what a user in the "Nurse" role would see after selecting
the clinical element "Patient". ProjectFlow also helps users manage activities by
prioritizing tasks associated with each of their assigned roles. For example, the "Filter
by Tasks" dropdown (Figure 2.3A2) lists the number of patient-related tasks that
must be performed within each stage of a workflow. Prior to using ProjectFlow for
study management, new staff undergo a 1.5-h training. Trainees must demonstrate a
clear understanding of study workflows as well as how to navigate and manage their
tasks using the application dashboards. For more details on dashboard functionalities,
see the Figure 2.3 caption.

Pausing workflows and audit tracking
Clinical studies occasionally encounter unexpected situations that require additional
discussion before proceeding. ProjectFlow allows clinical elements to be placed on
"HOLD" by flagging them within a workflow to allow time for issue resolution (Figure 2.3A4, red circle). When an element is placed on hold, the user may enter
questions/comments or even assign follow-up to a different role. The role performing the follow-up may choose to provide the necessary information or may instead
remove the element from the workflow entirely. Furthermore, to assure research integrity, clinical studies must maintain a record of actions for longitudinal auditing
purposes. ProjectFlow facilitates record maintenance by logging critical information
for each clinical element. Specifically, each element’s entire path through a workflow
is recorded, including but not limited to, the users performing the tasks, when each
18

Figure 2.3: ProjectFlow dashboard showing "Patient" clinical element views for the "Nurse"
user/role. (A) Clinical elements appear at the top of the dashboard (red oval). In this
example, a "Nurse" has already selected the element "Patient." (A1) The "All" tab lists
tasks (complete, incomplete or on hold) assigned to any user/role. The "Assigned To Me"
tab displays only tasks the Nurse role may execute. The Nurse has the ability to "release"
the task after which it would appear in the "Patient Tasks" tab which lists all unassigned
patient tasks. (A2) The "Filter by Tasks" dropdown shows which tasks require action by
the Nurse as well as the number of patients for which that task must be performed. (A3)
Data associated with a given patient or task may be queried using the search fields. (A4)
In order to complete a task, the Nurse clicks the arrow ">" to open the "Complete Task"
view. (B1) The Complete Task view displays relevant patient data. (B2) For this particular
task the Nurse must decide whether or not to cancel the patients existing prescription order.
(B3) After data entry, the task is completed by hitting the "Next" button. (B4) To view
the workflow in its entirety and see which stage of the workflow a patient is currently in;
the Nurse may select "View Workflow". (B5) The "History" panel lists completed workflow
steps for the patient as well as which users completed them and when.
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task is completed as well as all instances whereby an item was placed on hold or
re-assigned to another user/role for completion.

2.3.2

Customized study workflows supported by
ProjectFlow

Conceptual descriptions of the clinical study workflows supported by ProjectFlow for
both RePOP and DCP are shown in Figure 2.4. As ProjectFlow accesses enterprise
EHR data for provider and patient eligibility screening, both studies utilize it to
automate and track study recruitment and enrollment.

RePOP workflows
RePOP recruits and enrolls patients interested in sharing their de- identified electronic health data with the Precision Oncology Data Repository (PODR) for the
purpose of innovating (VA) cancer treatment(Do et al., 2019)(Elbers et al., 2020). To
aid recruitment efforts, the ProjectFlow database has nightly extract transform load
(ETL) processes that harvest the most recent available data for the RePOP cohort.
The cohort consists of patients who, as part of their standard of care, have undergone
or intend to undergo tumor-targeted genomic sequencing to further personalize their
oncology treatment. Utilizing the "ProviderRolodex" workflow (Figure 2.4A, blue),
providers are emailed study details and asked if their patients may be contacted to
participate. If physician approval is granted, the "PatientConsent" workflow (Figure
2.4A, purple) is used to generate and manage postal mailings containing detailed
study information, consent forms, and pre-paid return envelopes. The returned mail-
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ings with signed consents are tracked by study staff in ProjectFlow.

DCP workflows
DCP is a POCCT which evaluates the relative effectiveness of two widely prescribed
thiazide-diuretics used in the treatment of hypertension, that is HCTZ and CTD.
DCP utilizes existing enterprise EHR data for provider and patient eligibility screening and recruitment (Figure 2.4B, blue, orange). First, EHR data housed in CDW is
queried to identify qualifying providers and their associated living patients currently
treated with HCTZ for hypertension. Providers’ contact information is loaded into
the trial DB and the ProjectFlow workflow "EmailProviders" is initiated (Figure 2.4B,
blue). Providers are emailed study details and notified that they will receive a CPRS
"View Alert", as exemplified in Figure 2.2A, to confirm or decline participation in the
DCP trial; this process is managed and tracked via the "Physician Consent" workflow (Figure 2.4, orange). Providers may give permission for DCP staff to contact
their qualifying patients about enrolling in the trial. Provider response to the View
Alert, that is "sign" to approve, "discontinue" to decline, is subsequently captured
by ProjectFlow via daily CDW extracts.
For consenting providers, a "Patient Search" algorithm pulls contact information for
their eligible patients into the trial database and ProjectFlow application. The study
Call Center then telephones eligible patients to inform them about the study and ask
if they would like to participate. This patient contact and consent process is scripted
and tracked within the ProjectFlow "Call Center" workflow (Figure 2.4B, green).
Consented patients are processed through the "RandomizePatient" workflow (Figure 2.4B, purple). Where relevant, physicians receive a view alert to approve or decline
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Figure 2.4: RePOP and DCP tasks managed and tracked by ProjectFlow. (A) RePOP
workflows primarily support recruitment and enrollment (consenting) of patients. (B) DCP
workflows not only support recruitment and enrollment but also study randomization and
monitoring of prescription orders. Detailed descriptions of the workflows are provided in
the main text.
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patient randomization to CTHD (Figure 2.2B). Patients approved for randomization
to CTHD are mailed detailed drug safety information. Those declined randomization
are removed from the study eligibility list and sent a decision letter.

2.4
2.4.1

Results
Current status and application usage

The ProjectFlow application supports multiple study management functions and both
RePOP and DCP have used the application to track recruitment and enrollment of
providers and/or patients. It should be noted that patient enrollment numbers are
most often related to the length of time a VHA site (hospital) has been participating
in the study and not site-specific effort or engagement. To protect site confidentiality
and assure continued enrollment safety, we do not specify VHA hospital locations
(city, state) nor site-specific enrollment/randomization numbers.

Research Precision Oncology Program
Since 2017 over 11600 tasks have been executed in ProjectFlow by project managers,
research nurses, and IT staff to track enrollment for RePOP at 41 VHA hospitals in
29 geographically distributed US states. As of January 2021, it has enrolled >370
patients and evaluated >3800 potentially eligible patients at 40 VHA hospitals across
the United States. With the intent of enabling translational research to benefit our
Veterans, de-identified, longitudinal clinical, targeted tumor sequencing, and medical
imaging (CT and pathology slide) data from consented RePOP patients is available
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to all researchers via the Veterans Precision Oncology Data Commons (VPODC)(Do
et al., 2019)(Elbers et al., 2020).

Diuretic Comparison Project
Since 2017, DCP has utilized ProjectFlow to conduct and track over >230 000 tasks.
To do this the application has been accessed >15000 times by call center staff, research
nurses, project managers, and IT staff. It has also been used by the study call center
to track phone calls made for recruitment as well as patient consent. As of January
2021, ProjectFlow has supported tracking of (and prescription ordering) for over
3500 providers and over 10 000 patients at 63 VHA hospitals across 39 geographically
distributed US states.

2.5

Discussion

In contrast to explanatory trials, where the supporting infrastructure from patient
selection to data collection is optimized to evaluate treatment efficacy, a pragmatic
trial’s infrastructure aspires to compare treatment effects with minimal interference in
clinical practice; this often means relying on workflows that utilize the EHR. Indeed,
merging research and clinical processes enables the use of longitudinal EHR data for
study recruitment, enrollment, and monitoring. This can help reduce study costs and
facilitate realization of a learning healthcare system through the direct translation of
research evidence into clinical practice(Staa et al., 2012)(Vickers & Scardino, 2009).
To successfully implement a pragmatic trial as a point of care clinical trial using the
EHR requires flexibility and ease of integration that are not readily available in most
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commercial and open-source trial management tools. Here, we have described our
efforts with developing a software application that can support complex, customized
workflows for POC-R task management while simultaneously integrating with VHA
EHR infrastructures.
Initiated in 2016, the DCP study is one of VHA’s largest POCCTs to date. Like other
lengthy studies, DCP has evolved since its inception, including ongoing adjustments
to the study protocol and overarching design. ProjectFlow’s flexible workflow configuration has allowed us to adapt to these changing requirements and better manage
more fluid tasks and successfully maintain continuity of study operations over-time.
RePOP similarly has been able to iterate through protocol versions while the workflows in ProjectFlow were adapted accordingly. An example of this flexibility was a
change from multi-level consent to one-level consent, which was accommodated by
updating the variables in the consent steps to reflect the new consent form.
ProjectFlow’s use of rule-based access control has also proven valuable in unexpected
ways. Both RePOP and DCP studies have spanned several years and naturally undergone staff turn-over. Creating "trainee" roles with limited task scope and data
access has helped new personnel learn our overarching POC-R study processes and
workflows before moving into more formal, "expert" roles with greater scope and access. Similarly, the task prioritization feature of ProjectFlow’s dashboards has not
only helped experienced users manage their workload but increased new staff efficiency by serving as a reminder system that enhances learning. The application’s
"Note" text-entry feature, within its "Hold" functionality, has allowed staff to pause
workflows and communicate on an individual case basis when questions arise. This
has been particularly useful for DCP, which enrolls thousands of patients, as it can
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reduce the need for separate email communication thereby helping maintain all necessary information within one auditing system.

In addition to customizable workflows, one of ProjectFlowâs most useful features
is its ability to integrate seamlessly within the VHA EHR ecosystem. This minimizes
disruption in clinical care while facilitating data management tasks. More specifically,
for the DCP study, combined use of embedded CPRS View Alerts for data capture
and CDW connections for data extraction greatly minimized the need for manual
data entry by study staff and prescription monitoring via chart review. These features have also made ProjectFlow a useful recruitment tool for the VHA Integrating
Pharmacogenetics in Clinical Care (I-PICC)(Brunette et al., 2020) trial aimed at assessing if genetic testing can effectively aid personalization of statin medications for
cardiovascular disease treatment.

2.5.1

Limitations

ProjectFlow grants users significant flexibility in the types of workflows they may create. However, we have found that formal creation of BPMN workflows may require
greater knowledge of database design and web-service protocols than the average
trialist or clinical user may have. Thus, the overall maintenance and configuration
of the application likely requires oversight by a software development team rather
than being managed solely by trialists or clinicians. Additional work is required for
reducing application complexity to allow management by the average user. Furthermore, as ProjectFlow’s primary database is optimized to facilitate maintenance of
the application itself, additional database structures designated for tracking and re26

porting study-specific outcomes on a project by project basis would be useful. More
specifically, we have found that formal reporting may be complicated for clinical and
reporting staff who are less familiar with the innerworkings of the application and
workflows. Presently, to close this gap, database engineers create study-specific views
and tables for reporting which may then be used by trialists for reporting.

2.6

Conclusion

POC-R aims to integrate research processes within day-to-day clinical operations and
utilize patient EHR data for study recruitment, monitoring, and outcome reporting.
The implementation of ProjectFlow to support both the DCP and RePOP studies
afforded us significant flexibility to create customized study workflows for task management while simultaneously integrating with VHA enterprise EHR infrastructures.
To date, ProjectFlow has facilitated management of study recruitment, enrollment,
randomization, and drug orders for over 10 000 patients for the DCP clinical trial. It
has also helped us evaluate over 3800 patients for recruitment and enroll over 370 of
them into RePOP for use in data sharing partnerships and predictive analytics aimed
at optimizing cancer treatment in the VHA. More recently, the application has also
been used to support the VHA I-PICC trial.
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Chapter 3
The Veterans Affairs Precision Oncology Data Repository, a Clinical, Genomic, and Imaging Research
Database
This Chapter is derived from Elbers & Fillmore et al. (Elbers et al., 2020)
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3.1

The Bigger Picture

Accelerating the speed of innovation and discoveries in health care requires the liberation of real-world data from their silos. One of the greatest challenges in the
application of artificial intelligence and machine learning to health care is the validation of new algorithms beyond where they were created. We present the Veterans
Affairs Precision Oncology Data Repository (VA-PODR), a large-scale repository of
de-identified data on patients diagnosed with cancer at the Department of Veterans
Affairs (VA). VA-PODR includes longitudinal clinical, genomic, and imaging data
originating from the VA’s electronic health record system, the VA Central Cancer
Registry, and other sources. VA-PODR enables researchers around the world to validate their algorithms and advance cancer research and health care in general. In
addition, VA-PODR enhances Veterans’ health care by facilitating development of
algorithms that are well tuned to the Veteran population and ready for deployment
inside the VA.

3.2

Summary

The Veterans Affairs Precision Oncology Data Repository (VA-PODR) is a large,
nationwide repository of de-identified data on patients diagnosed with cancer at the
Department of Veterans Affairs (VA). Data include longitudinal clinical data from the
VAâs nationwide electronic health record system and the VA Central Cancer Registry, targeted tumor sequencing data, and medical imaging data including computed
tomography (CT) scans and pathology slides. A subset of the repository is available
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at the Genomic Data Commons (GDC) and The Cancer Imaging Archive (TCIA),
and the full repository is available through the Veterans Precision Oncology Data
Commons (VPODC). By releasing this de-identified dataset, we aim to advance Veterans’ health care through enabling translational research on the Veteran population
by a wide variety of researchers.

3.3

Introduction

The Department of Veterans Affairs (VA) operates the largest integrated health care
system in the United States and was an early adopter of electronic health record
(EHR) systems(Brown, 2003). As a result, the VA has large longitudinal databases
containing health records dating back as far as the 1980s, with comprehensive coverage starting in 1999(Corporate Data Warehouse (CDW), n.d.). More recently, the VA
launched the Precision Oncology Program (POP), initially in the New England region under leadership of our group at the Boston Cooperative Studies Program (CSP)
Informatics Center(L. D. Fiore et al., 2016)(L. Fiore et al., 2016), and subsequently
as a national program led by the VA’s National Oncology Program(Kelley, Duffy,
Hintze, Williams, & Spector, 2017). Under POP, the VA has carried out targeted
tumor sequencing on a national scale for Veterans diagnosed with cancer.
Although the VA has established successes in the care for cancer patients through
evidence-based approaches, to accelerate this progress even further, it is critical to
combine expertise from both inside and outside the VA. To that end, our group established the Research Precision Oncology Program (RePOP), which provides a mechanism for patients to consent to broad data sharing for research purposes. This, along
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with additional work to assure regulatory compliance, enables the VA to contribute
data into the cancer data ecosystem as recommended by the Cancer Moonshot Blue
Ribbon Panel(Singer, Jacks, & Jaffee, 2016)(“Blue Ribbon Panel Report”, 2016). For
example, consent obtained under RePOP has facilitated the VA’s participation in the
Cancer Moonshot’s Applied Proteogenomics OrganizationaL Learning and Outcomes
(APOLLO) network(FACT SHEET: At Cancer Moonshot Summit, Vice President
Biden Announces New Actions to Accelerate Progress Toward Ending Cancer As We
Know It, 2016).
Due to these efforts, we are now able to share VA data as a national resource to investigators inside and outside the VA. Specifically, in this paper, we introduce the VA
Precision Oncology Data Repository (VA-PODR) and describe its availability outside
the VA. VA-PODR consolidates de-identified VA clinical, genomic, and imaging data
needed for research in precision oncology in a large, nationwide repository. The data
consist of longitudinal clinical data from the VA’s integrated EHR system and the
VA Central Cancer Registry, targeted tumor sequencing data, and medical imaging
data including computed tomography (CT) scans and pathology slides.
In previous work, we described the VPODC, a data-sharing and computational platform where VA-PODR is available to researchers outside the VA(Do et al., 2019).
Here, in contrast, we describe the VA-PODR data repository itself. The difference between the VPODC and VA-PODR is that the VPODC is a specific platform through
which the VA-PODR dataset is shared and collaborative analysis can take place.
However, the VPODC is not the only place where VA-PODR is available. Parts of
VA-PODR are also shared in the Genomic Data Commons (GDC)(Genomic Data
Commons, n.d.) and The Cancer Imaging Archive (TCIA)(Clark et al., 2013), as well
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as internally at the VA. And, in the future, it is our intention that VA-PODR will be
made available elsewhere as well.
VA-PODR represents a unique resource, for several reasons. First, to our knowledge,
VA-PODR is the first large-scale repository of VA health data that has ever been
made available to researchers outside the VA. Second, VA-PODR is one of only a
handful of large-scale databases with real-world EHR data to be made available to
the research community outside the institutions where the data originated, similar
to the widely used MIMIC Critical Care Database(Johnson et al., 2016), but in a
different medical domain. Third, VA-PODR combines clinical, genomic, and imaging
data, enabling multimodal analysis that is not possible with only one source, similar
in some respects to The Cancer Genome Atlas (TCGA)(Weinstein et al., 2013), but
with substantially richer clinical data.
In addition to VA-PODR’s use for observational research in precision oncology, we
envision VA-PODR facilitating big data research in health care in general, such as
for the development and validation of analytical models and other tools using large
EHR, genomic, and imaging data, and also being used for educational purposes. Thus,
our contribution will benefit both Veterans and the broader community by providing
accessible data to accelerate improvement in health care.
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3.4
3.4.1

Results and Discussion
Methods

Repository Development
VA-PODR consists of (1) de-identified longitudinal clinical data from the VAâs integrated EHR system and the VA Central Cancer Registry, (2) targeted tumor sequencing data from POP, and (3) medical imaging data including CT scans and pathology
slides. Data from multiple sources is pulled to a central location, and records are
matched using internal patient identifiers (Figure 3.1).
Clinical data include 10 domains, 38 tables, and 647 columns, and approximately 1
billion rows of data from the VA’s EHR system, with detailed information on demographics, survival, laboratory test results, orders, medications, surgeries, and visits,
including associated ICD and procedure codes, and more.
This information is available in the VA Corporate Data Warehouse’s native data
model as well as in the VA’s implementation of the Observational Medical Outcomes
Partnership (OMOP) Common Data Model (CDM). Our intention is for VA-PODR
to include all information from the EHR that is relevant for research. In addition,
extensive curated data on cancer diagnosis, treatment, and outcomes is included from
the VA Central Cancer Registry (VACCR)(Zullig et al., 2012), which collates data
on cancer cases that have been annotated by VA cancer registrars throughout the
nation.
Genomic data include data generated under both the VA New England Healthcare
System Precision Oncology Program(L. Fiore et al., 2016)(L. D. Fiore et al., 2016)
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Figure 3.1: Overview of the VA-PODR Dataflow. Data are pulled from several sources
within the VA, aligned and de-identified in the landing zone, and subsequently submitted to
collaborating repositories.
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and the VA National Precision Oncology Program(Kelley et al., 2017). These data
consist of targeted tumor sequencing data, including both raw sequencing files and
somatic variant calls.
Medical imaging data are extracted from two distinct sources. CT scans taken at
or near diagnosis are pulled from various VA’s medical centers’ Picture Archiving
and Communication Systems. In addition, images of pathology slides from sequenced
tumor biopsies are included; these were produced by the vendors carrying out the
targeted tumor sequencing described above, or are histopathology slides digitized at
local pathology departments.

De-identification
General Strategy Before release, all data are de-identified in accordance with both the
United States Health Insurance Portability and Accountability Act (HIPAA)(Office for
Civil Rights, 2012) and internal VA requirements, including VHA Handbook 1200.12
guidelines(ORD VHA Directive, Handbooks, and Program Guides – 1200 series, 2022).
Specifically, all data elements covered under HIPAA as identifiers are removed, as well
as other possible sensitive information, identified as such by subject matter experts
(SMEs); see details below. After de-identification using the procedures below, all
data are reviewed and approved by a VA Privacy Officer before release.
In all data types, dates are obfuscated by calculating days to an arbitrary patientspecific anchor date. This procedure preserves the ordering of dates within each
patient’s timeline. No patient data are included for which the timestamp indicates
that it was collected at the time a patient is 90 years of age or older.
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Clinical Data
As briefly mentioned above, the clinical data are de-identified through a manual review for identifiers under HIPAA, sensitive information, and/or other PHI/PII by
SMEs. Specifically, each column of data is assessed for inclusion or exclusion based
on whether it primarily contains this type of information, which can occur in categorized fields or free text, or not. Columns that primarily contain sensitive information
are excluded. In addition, for columns that are included, each distinct data value
is evaluated for sensitivity by an SME and either excluded or added to a white list.
Examples of sensitive data are medication discontinued dates, serial codes, and references to physicians and locations. As new data are added, they are checked against
the white list and flagged for manual review if not present (Figure 3.2). Thus, SMEs
are involved in two steps: first in assessing each new column and deciding if the
column in its entirety contains sensitive and/or HIPAA information and second in
reviewing new and distinct varchar values and deciding if this specific value should
be white- or blacklisted while the column itself is part of PODR.

Genomic Data
Genomic data are de-identified by removing any HIPAA identifiers occurring in metadata associated with each record and certifying this de-identification methodology by
an SME. Genomic data of tumors are not considered inherently identifiable under US
regulations(Dankar, Ptitsyn, & Dankar, 2018).

Imaging Data
For imaging data, we ensure that both headers and image content do not include
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Figure 3.2: Review Process to Exclude Sensitive and Identifiable Data. Once a cohort is
requested, new data are pulled and unique values are compared with data values previously
evaluated. New data values are evaluated by SMEs and either white- or blacklisted. The
new dataset is filtered by the white-listed dataset, de-identified, and shared.
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sensitive or identifying information. Sensitive data in Digital Imaging and Communications in Medicine (DICOM) headers are removed through a process similar to
that used for clinical data. To de-identify image content, we use the Medical Imaging
Resource Community’s Clinical Trials Processor software(Langer et al., 2015).

Technical Validation
Data have been validated three ways. Best practices have been used in developing
code to pull and collate data, relying on standard internal VA identifiers to join data
across domains where possible, and subsequently translating these to public identifiers. In addition, all data domains and values have been reviewed by a group of
SMEs with expertise in medicine, imaging, and data analysis. Finally, all data have
been reviewed and certified as de-identified by a VA Privacy Officer before release.

Risk of Re-identification
In sharing VA-PODR data, de-identification standards have been adopted, extended,
and thoroughly vetted to protect VA patients. In order to further mitigate residual
re-identification risk in the de-identified datasets, we have also implemented policy
controls. Specifically, the larger set of de-identified data is available only after proof of
institutional privacy policies, vetting of data transfer rules, and signing of a Data Use
Agreement (DUA), in which the user agrees not to attempt re-identification. These
measures are further detailed in the next section.
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Regulatory Considerations
In accordance with VA regulations, VA data can be housed in a database, a single
repository, or a data repository. A database is explicitly created in the course of
conducting research, while a single repository can be used to archive/compile data
from multiple protocols and/or investigators working on similar topics. VA-PODR
is a data repository, meaning that it is a living document that details the sources
and contents of archived research data and also describes all secondary use of data
including where the data go, who uses them, for what purposes, over time. VA-PODR
currently describes two cohorts, A and B, with their regulations detailed below. We
anticipate other cohorts will be added to VA-PODR in the future, whether prospective
or retrospective, observational or interventional, of which APOLLO is an example.

Cohort A Consent and HIPAA Authorization
For patients in cohort A, consent and HIPAA authorization was obtained to share
data with partners inside and outside the VA. Inside the VA, data on patients in
cohort A can be shared either identified or de-identified while coded or anonymized,
depending on the investigator’s protocol and the details of the DUA signed with
PODR. Outside the VA, data on patients in cohort A can only be shared after they
are de-identified and coded or anonymized and a DUA is signed with PODR. This
DUA may allow data on patients in cohort A to be reshared. The signed DUA will
state that re-identification is prohibited.

Cohort B Decedent and HIPAA Waived
Patients in cohort B need to be recorded as decedent in their medical record; iden40

tification of these patients is performed under an HIPAA waiver. Decedent data
are not considered data on human subjects. Similar to cohort A, inside the VA,
data on patients in cohort B can be shared either identified or de-identified while
coded or anonymized, depending on the investigator’s protocol and the details of the
DUA signed with PODR. Outside the VA, data on patients in cohort B can only
be shared after they are de-identified and coded or anonymized and under a DUA
signed between PODR and a trusted partner with a standard operating procedure
or institutional review board-approved protocol. Different from cohort A, these data
cannot be reshared and must remain in the trusted partner’s repository. The signed
DUA will state that re-identification is prohibited.

Unanticipated Events
If an unanticipated event occurs with PODR data, the procedures in the most recent
version of the PODR protocol and VA handbook 1200.05 are followed. The event
is reported to the privacy officer, principal investigator, quality assurance manager,
institutional review board, and RD committee at the VA Boston Healthcare System.
In addition, the event is entered into a national privacy database by the privacy
officer, and a determination is made on the need for corrective action.

3.4.2

Results

Patient Characteristics
In its current release, VA-PODR includes data on 113,154 Veterans diagnosed with
cancer at the VA, including 1,115 patients who were enrolled in POP. Details on
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Characteristic

VA-PODR (N = 113,154), n (%)

Age
<50 years
50-59 years
60-69 years
70-79 years
≥ 80 years

391 (0.4)
7,215 (6.4)
38,170 (33.7)
37,151 (32.8)
30,227 (26.7)

Gender
Male
Female
Race

111,811 (98.8)
1,343 (1.2)

African American
American Indian
Asian
White
Native Hawaiian/Pacific Islander
Unknown
Ethnicity

20,531 (18.1)
512 (0.5)
247 (0.2)
77,295 (68.3)
668 (0.6)
13,901 (12.3)

Hispanic or Latino
Not Hispanic or Latino
Unknown

3,624 (3.2)
99,862 (88.3)
9,668 (8.5)

Table 3.1: Demographic Characteristics of the VA-PODR Patient Population. (Patients
can report multiple races.)

demographics, date of diagnosis, and cancer type are shown in Tables 3.1, 3.2, and
3.3. Patients in VA-PODR are predominantly older (26.7% ≥ 80 years, 32.8% 70-79
years, 33.7% 60-69 years, 6.4% 50-59 years, and only 0.4% <50 years) and male (98.8%
male, 1.2% female). The cohort includes 18.1% African American and 68.3% white
patients. Cancer types include prostate (58,323 patients), lung (56,836), bladder
(3,640), skin (2,168), colon (2,043), and kidney (1,284) cancer, among others. Year
of diagnosis ranges from 2005 to 2019, with 2.6% of diagnoses in 2004 or earlier.
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Cancer Type
Prostate
Lung
Bladder
Skin
Colon
Kidney
Other

VA-PODR (N = 113,154), n (%)
58,323
56,836
3,640
2,168
2,043
1,284
11,963

(51.5)
(50.2)
(3.2)
(1.9)
(1.8)
(1.1)
(10.5)

Table 3.2: Distribution of Cancer Types in the VA-PODR Patient Population as Reported
by the VACCR.(Patients can report multiple races.)

Year of Diagnosis

VA-PODR (N = 113,154), n (%)

≤ 2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
Unavailable

2,986 (2.6)
7,158 (6.3)
6,658 (5.9)
6,918 (6.1)
6,004 (5.3)
6,752 (6.0)
12,517 (11.1)
11,710 (10.3)
10,742 (9.5)
9,784 (8.6)
9,203 (8.1)
8,316 (7.3)
6,698 (5.9)
5,080 (4.5)
2,336 (2.1)
106 (0.1)
270 (0.2)

Table 3.3: Year of Diagnosis of Cancer in the VA-PODR Patient Population as Reported
by the VACCR
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Efforts are underway to expand VA-PODR to include all lung cancer patients
within the VA since 1999 (approximately 150,000 cases) and add at least 100,000
prostate cases. Ultimately, we intend all known cancer cases at the VA to be included
in VA-PODR. We are also conducting iterative updates of images and genomic data
as they become available, as well as expanding clinical data domains to, for example,
include the inpatient and radiology domains. We are open to input from the research
community on determining expansion priorities.

Classes of Data
Clinical data are stored in a relational database for the following domains: outpatient
visits, inpatient medications, outpatient medications, all laboratory test results, all
orders, surgery, and patient demographics. Clinical data also include cancer registry
data and a derived table containing all ICD codes and timestamps associated with
each patient across several domains (Table 3.4).
Genomic data are stored in individual files, linked to clinical data by filename identifiers. Genomic data include three levels of detail: raw sequencing data in FASTQ
format, somatic mutation data stored in VCF format, and information on actionable
mutations based on curation by molecular diagnostic vendors. Two vendors were
used: Personalis, which used the ACE Cancer Plus panel, and PGDx, which used
the Cancer Select 203 panel. Information on which vendor was used for each patient
sample is available in the metadata.
Imaging data are stored as DICOM stacks in Orthanc(Jodogne, 2018), an open
source PAC server, and are linked to the clinical data by patient identifiers. A set of
the metadata extracted from the DICOM tags is available in table format for direct
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Domain Table Name

Description

BCMAMedicationLog
Inpatient medications
CPRSOrder
All orders for drugs, labs, etc.
OutpatVDiagnosis, OutpatVisit,
OutpatVPatientEd, OutpatVProcedure,
OutpatVProcedureDiagnosis,
OutpatVSkinTest,
OutpatVSkinTestDiagnosis
Outpatient visit information
PatientLabChem
Laboratory test information
Patient income information
PatientMeansTest
Patients
Basic demographic and vital status information
Pharmacy outpatient
RxOutpat
SurgeryPRE, SurgeryINTRA,
SurgeryPOST,
SurgeryProcedureDiagnosisCode
Surgery data
ICDCode
All ICD codes with timestamp
VA Central Cancer Registry Data
OncologyPrimary
OMOP
The Observational Medical
Outcomes Partnership (OMOP)
Common Data Model (CDM)
Table 3.4: Data Domains Available in VA-PODR

querying.

Clinical Data Domains
VA-PODR contains a broad range of longitudinal clinical data both from the VA’s
EHR system and from the VACCR. EHR data in VA-PODR include information on
patient demographics, comorbidities, procedures, medications, laboratory test results,
medical orders, survival, as well as detailed administrative information arising from
inpatient and outpatient visits to the VA. In addition, VACCR data in VA-PODR
include extensive manually annotated information on cancer cases and outcomes.
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Repository Access and Locations
VA-PODR at present consists of two different cohorts with different access policies.
Cohort A includes patients who have consented to broad data sharing with parties
external to the VA under the RePOP protocol. Cohort B includes patients who are
deceased and are not considered human subject research, but by internal policy is
subject to additional restrictions compared with cohort A. In the future, additional
cohorts may be added.
A subset of VA-PODR data from patients in cohort A is available at the Genomic Data Commons(Genomic Data Commons, n.d.)(Grossman et al., 2016) and
TCIA(Clark et al., 2013)(TCIA Collections, n.d.) and our intention is that relevant
data elements from all of cohort A will be available at these locations in the future.
All VA-PODR data for cohort A are available at the Veterans Precision Oncology
Data Commons (VPODC)(The Veterans Precision Oncology Data Commons, n.d.)
to approved users who provide proof of institutional privacy policies and data transfer rules to the data steward. Cohort B is also accessible at the VPODC through
the data steward and with the approval of the data owner (VA). Like the GDC, the
VPODC is a platform for data sharing and analysis in the Gen3 commons framework
developed by the University of Chicago(Grossman et al., 2016).
To request access to VA-PODR via VPODC, users should send an access request
email to the contact listed at https://vpodc.org. The initial email should include
a description of the research topic, the cohort to which access is requested, and
institutional details. Access requests will be reviewed and prioritized by an allocations
committee. Before data access is granted, all users will be required to complete
training on privacy and information security. In addition, users will be required to
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sign the applicable and most recent version of the DUA.

FAIR Principles
VA-PODR aligns with the FAIR principles(Wilkinson et al., 2016) that data should
be findable, accessible, interoperable, and re-usable. A full data dictionary is included in VA-PODR and available at the VPODC. In the GDC and TCIA, the data
follow the data structures mandated and documented by those frameworks, creating
a findable and rich metadata structure with unique and persistent identifiers. The
VPODC, GDC, and TCIA follow interoperable standards for authentication, access,
and retrieval. The subset of VA-PODR data that follows the OMOP data structure
allows for interoperability with other health care data repositories, and the subset of
data available at GDC and TCIA follows those systems’ standards. Since data will
be housed long-term at these sites, it will remain findable and re-usable. Thus, we
believe that the VA-PODR satisfies the conditions of being FAIR.

Use Cases
In addition to VA-PODR’s primary use to enable research in precision oncology, the
dataset has substantial use for several other purposes of broad interest, including (1)
methods research in analysis using EHR data, (2) educational and training purposes,
and (3) development of clinical informatics tools. VA-PODR is particularly valuable
for these additional purposes, because there are currently few large EHR datasets
readily available to researchers or students who are not affiliated with an institution
that has an EHR data warehouse.
To date, VA-PODR data have been used in the Department of Commerce’s The
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Opportunity Project (TOP) Health Artificial Intelligence initiative(Deep Dive: How
a Health Tech Sprint Pioneered an AI Ecosystem, 2019)(TOP Health Sprint, n.d.) In
addition, VA-PODR data have been used to carry out external validation and calibration of a prognostic model for mortality among patients with non-small cell lung
cancer(Cheng et al., 2019)(N. Fillmore et al., 2019). In addition, research projects
on lung and prostate cancer using VA-PODR data and the VPODC platform are
underway.

3.4.3

Conclusion

We have described VA-PODR, a large, nationwide repository of de-identified data
on patients diagnosed with cancer at the VA. This repository contains longitudinal
clinical data from the VA’s nationwide EHR system and the VACCR, targeted tumor
sequencing data, and medical imaging. A subset of the repository is available at the
GDC and TCIA, and the full repository is available through the VPODC. By making
these data available, VA-PODR enables multiple uses of benefit to both Veterans and
the broader community.
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3.5
3.5.1

Experimental Procedures
Resource Availability

Data and Code Availability
VA-PODR is available at https://vpodc.org, and subsets of the data are available at
https://portal.gdc.cancer.gov/projects/VAREPOP-APOLLO and
https://wiki.cancerimagingarchive.net/display/Public/APOLLO-1-VA.The published
article reports on all data generated to date (July 25, 2020), and it is anticipated that
the data will be expanded. There are restrictions to the availability of data due to
privacy considerations, as described above.
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Chapter 4
An application to support COVID19 occupational health and patient
tracking at a Veterans Affairs medical center.
This Chapter is derived from Fillmore & Elbers et al. (N. R. Fillmore et al., 2020)
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4.1

Abstract

Objective: Reducing risk of coronavirus disease 2019 (COVID-19) infection among
healthcare personnel requires a robust occupational health response involving multiple
disciplines. We describe a flexible informatics solution to enable such coordination,
and we make it available as open-source software. Materials and Methods: We developed a stand-alone application that integrates data from several sources, including
electronic health record data and data captured outside the electronic health record.
Results: The application facilitates workflows from different hospital departments,
including Occupational Health and Infection Control, and has been used extensively.
As of June 2020, 4629 employees and 7768 patients and have been added for tracking
by the application, and the application has been accessed over 46 000 times. Discussion: Data captured by the application provides both a historical and real-time view
into the operational impact of COVID-19 within the hospital, enabling aggregate and
patient-level reporting to support identification of new cases, contact tracing, outbreak investigations, and employee workforce management. Conclusions: We have
developed an open-source application that facilitates communication and workflow
across multiple disciplines to manage hospital employees impacted by the COVID-19
pandemic.

4.2

Introduction

The incidence of coronavirus disease 2019 (COVID-19) in healthcare personnel has
been reported to vary between 3.8% and 38.9%(Chou et al., 2020)(CDC COVID-19
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Response Team, 2020). Multiple strategies have been proposed to manage and protect these critical individuals during the pandemic(Ehrlich, McKenney, & Elkbuli,
2020)(Adams & Walls, 2020)(Shanafelt, Ripp, & Trockel, 2020)(Semple & Cherrie,
2020)(Nagesh & Chakraborty, 2020)(Godderis, Boone, & Bakusic, 2020)(Gan, Lim,
& Koh, 2020). Risk reduction strategies involve using policies, processes, and technologies to address screening, testing, monitoring, and quarantining. Characterizing
the workforce by occupation, location, symptoms, exposures, and test results is critical to formulate and implement risk reduction strategies, and these data vary over
time(Adams & Walls, 2020)(Adalja, Toner, & Inglesby, 2020)(Baker, Peckham, &
Seixas, 2020). The fragmentation of information challenges occupational health staff,
infection prevention nurses, and clinical providers to effectively understand the pandemic’s impact on the workforce of an institution in real time. There is a growing
number of technology platforms and applications to augment the workflow of screening the patient population, tracking infections, monitoring supplies, and self-triage to
support clinical operations(Dong, Du, & Gardner, 2020)(Judson et al., 2020)(Vaishya,
Haleem, Vaish, & Javaid, 2020)(Berry, Soucy, Tuite, & Fisman, 2020). There is also
an increasing number of applications that focus on categories such as âdiagnosis,
prevention, treatment, adherence, lifestyle, and patient engagementâ(Patel et al.,
2020)(Hollander & Carr, 2020)(Reeves et al., 2020)(Golinelli et al., 2020). Although
these technologies tackle many important public health concerns, they have not provided adequate support for a comprehensive healthcare system’s occupational health
response to the pandemic.
From March through May of 2020, Boston was among the most significantly affected metropolitan areas in the United States with new COVID-19 cases. Several
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organizations such as The New York Times and Johns Hopkins University report data
on COVID-19 cases and related deaths, facilitating understanding of the epidemic at
a national and state level. Dashboards such as the COVID-19 Watcher have been
created to quickly ascertain information such as the number of cases in Boston and
how the city compares to other cities as regards to prevalence of COVID-19(Wissel et
al., 2020). However, it is extremely difficult to quickly determine how many patients
and employees are diagnosed with or potentially to COVID-19 infections on a daily
basis at an institutional level. Applications have been developed that use information and configurable tools from the electronic health record (EHR) to track persons
under investigation and infected patients in hospitals(Reeves et al., 2020), but questions related to potential exposures and testing of employees are often difficult to
answer quickly because complete employee health records are not routinely found in
the hospital’s EHR.

4.3

Objective

We describe our COVID-19 Data Management Platform (COVIDDMP), a flexible
informatics solution to facilitate communication and workflow across multiple disciplines in response to the rising occupational exposure to COVID-19. We discuss how
our application can quickly adapt to the evolving policies and procedures for protecting healthcare workers as the pandemic progresses. The application is available as
open-source software for use by other healthcare systems
(https://github.com/bostoninformatics/COVIDDMP). The open-source approach allows us to create a flexible framework that can be adapted to integrate data from
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different sources and interoperable with a range of EHR platforms.

4.4

Materials and Methods

The Veterans Affairs Boston Healthcare System (VABHS) comprises 3 campuses and
5 Community-Based Outpatient Clinics, providing a comprehensive range of services
including primary and specialty care, surgical and emergency services, and short-term
and long-term community living centers. Like other healthcare centers throughout the
Department of Veterans Affairs (VA), VABHS uses the Veterans Health Information
Systems and Technology Architecture (VistA) as the EHR(Brown, 2003).Real-time
access to VistA data by third-party applications is tightly controlled, but VistA data
from all VA medical centers are collated in a large data warehouse, the Corporate
Data Warehouse (CDW), and updated nightly(Fihn et al., 2014). Given the rapid development cycle and the need for real-time data, instead of seeking changes to VistA,
we chose to develop a stand-alone, open-source platform that integrates data captured
outside of the EHR and data exported from the EHR. This added the capability of
a 3 times per day VistA extract, utilizing FileMan(“VA FileMan Technical Manual”,
2021), the database management system of VistA, to extract near real-time reports,
and user-entered data, to the nightly data extract from CDW. Clinical stakeholders
determined a 3 times per day frequency of FileMan reports as being adequate for their
workflow. Our approach combines a Python-based engine and graphical user interface
in the form of a dashboard(Grinberg, 2018). The application is enhanced with access
controls and security and integrates with an underlying pipeline that accomplishes
data source harmonization and integration using R (version 3.6.3, R Foundation for
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Figure 4.1: System architecture. A scheduled R pipeline extracts data from the Corporate
Data Warehouse (CDW) nightly and from a FileMan export thrice daily, and loads this data
in the application’s COVID19 database. The front end, including a Windows Authentication
proxy and the Python-based web application, read from the application database and serve
results to the user.

Statistical Computing, Vienna, Austria) and SQL pipelines (Figure 4.1).
In order to develop and deploy COVIDDMP while policies and procedures are
evolving, a rapid and dynamic development structure was put in place. This involved early morning 30-minute scrums with the development team and late afternoon 30-minute check-ins with our stakeholders to update on progress and clarify
outstanding requirements. The development team consisted of data scientists, frontend and database engineers, report and quality assurance specialists, and system
administrators led by technical architects and project managers. The stakeholders
were clinicians, nurses and technical support staff from VABHS, primarily from occupational health, but other teams such as primary care and infectious disease were
involved as well. To track requirements, implement a software development life cycle,
and facilitate version control, the VA’s GitHub platform was utilized. This allowed
technical architects and project managers to create issues describing and prioritizing
the requirements and bugs, while developers check in their code and branch out to
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build features. When features passed quality assurance the code was merged back in
after careful review in a pull request by one of the technical architects. During the
initial phases of deployment, daily deployment occurred, which stabilized over time
to a weekly deployment cycle.

4.5
4.5.1

Results
Application Components

The resulting COVIDDMP consists of 4 main parts: the data extraction pipeline,
the database, the GUI application, and the integrated authentication. The data extraction pipeline has been written in R and SQL. It runs overnight to extract new
CDW data and every 15 minutes between 7 am and 7 pm to verify if new FileMan
data are available to be integrated into the COVID-19 database. The data extracted
from CDW and the FileMan report include new tests, test results, and persons under
investigation. In addition to this, the pipeline pulls data on the patient or employee
including contact information, hospitalization status, ward location, and the Patient
Aligned Care Team. The Microsoft SQL Server (version 11.0.7001, Microsoft Corporation) database maintains this extract, assigns unique person identifiers to maintain
data integrity, and stores a history of all data entered manually by the user. Users
are able to add new persons to the database and update or correct information on
existing persons. The COVIDDMP assumes that data entered or corrected by the
user takes precedence. If more recent data are available from the extract, this is
shown separately. This allows users to update the data in real time and not have to
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wait until the next data pull. This increases efficiency and improves clinical decision
making for the healthcare personnel accessing the database. To support rapid development and changing requirements, the COVIDDMPâs database table structure
follows a relatively flat, non-normalized model, relying on view structures to provide
the most recent data.
The Python-based GUI application contains Search, Add/Edit, and Reporting
tabs. The Search tab allows users to search for their person(s) of interest based
on dropdown variables such as type (eg, patient or employee) or ward location and
personally identifiable information. Frequently used settings are prepopulated and
available as options under the Search tab. Additionally, the Search tab allows the user
to track when persons were contacted, drill down to more detailed data or edit specific
data. The Add/Edit tab allows the user to add new persons into the application. Any
data that is already available in the CDW is preloaded in the application, including
contact information, demographic details, tests, symptoms, and other related areas.
The Reporting tab displays reports described in more detail subsequently.

4.5.2

Primary care and occupational health workflows

The platform was designed to facilitate multiple workflows from various hospital departments. We started with a results tracking workflow for primary care then expanded functionality for Occupational Health (OH). OH has 3 primary workflows
currently supported by the platform: (1) ensure that employees with positive COVID
test results are not at work; (2) return to work those who have been out on quarantine
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for more than 14 days; and (3) advance those on restricted duties to full duty when
clinically appropriate based on guidelines from the United States Centers for Disease
Control and Prevention. Using the information captured about the employees such
as symptoms, test results, work location, and occupation, a quarantine plan can be
conveyed to the employee and supervisor as well as managed on the platform. An
algorithm was created to expedite the assignment of a COVID status for an employee
based on the results of testing such as "COVID Positive Retest Pending" or "COVID
Positive 2nd Negative." A report can be generated by the OH team to show which employees have been out longer than 14 days and have not yet returned to work after 2
negative tests. Employees with restricted duties are captured in the application along
with notes from the OH team. Discussions are ongoing about developing workflow
features to manage duty restrictions. These features allow the OH team to efficiently
allocate which employees need reassessment.

4.5.3

Outbreak investigations report

Our Infection Control staff requested a patient level report that would support them
in identifying potential outbreaks at the hospital over a designated time frame. This
requires the ability to identify on which day and in which ward location of the hospital
a patient first tested positive and any subsequent locations to which the patient was
transferred. We configured the report to start 48 hours before illness onset per Centers
for Disease Control and Prevention guideline. Because COVIDDMP integrates data
from multiple VA facilities within the same interface, it allows for tracking of patients
who move across different VA facilities.
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COVID Status

Category

Under investigation,
monitoring,
or pending testing

Employees, Clinical Role
Employees, Non-Clinical Role
Employees, Quarantined, Undefined Role
Employees: Exposure; Return to Duty with Self-Monitoring
Patients: Inpatient status

Positive

Total tested

Employees: COVID Positive, Clinical Role
Employees: COVID Positive, Non-Clinical Role
Employees: COVID Positive, Undefined Role
Patients: Inpatient status PUI/Testing in Progress
Patients: Confirmed COVID-19 Positive VABHS
at BROCKTON (Inpatient)
Patients: Confirmed COVID-19 Positive VABHS
at WEST ROXBURY (Inpatient)
Patients: Outpatient status Confirmed COVID-19 Positive
Patients: COVID-19 Positive Inpatient Deaths

Employees: Completed COVID-19 Tests
Patients: Completed COVID-19 Tests

Table 4.1: Summary of report aggregation by COVID-19 status, person type, and temporal
period

4.5.4

Director’s daily briefing report

The VABHS leadership requested a daily briefing classified by clinical staff, patients,
and the unique category of employees who are also veteran patients. This report
is used to monitor healthcare system capacity, adjust staffing needs, and provide
published reports to the healthcare system staff (Table 4.1). Data are provided in
aggregate counts of every 24-hour period, as well as cumulatively since March 1, 2020.
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4.5.5

Application usage

Since initial deployment the week of March 16, 2020, the application has been used extensively by staff from OH, Infection Control, Primary Care, and other departments.
In total, 4629 employees and 7768 patients and have been added for tracking by
the application, with 44-759 employees and 128-871 patients newly added each week
between March 16 and June 8, 2020 (Figure 4.2). On average, there are 95 ± 192
updates per day to symptoms, tracking, contact, or other information. Altogether,
between April 2 and June 20, 2020, the application was accessed over 46 000 times.
In addition to direct usage of the application, data produced by the application are
broadly distributed; for example, counts from the Director’s Daily Briefing Report
(see previous) are distributed to all VABHS employees and affiliates every weekday
by email.

4.6

Discussion

Protecting healthcare personnel during the COVID-19 pandemic is critical both for
individual employee health and to enable continuity of operations. This is crucially
important in cities with high prevalence of the disease.
The data captured by our platform offer an opportunity to create patient-level
reports in an effort to support VABHS hospital staff and leadership with COVID19 monitoring and screening protocols. Integrating data entered by users into the
dashboard application with automated data captured by the VA electronic medical
record has provided both a historical and real-time view into the operational im-
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Figure 4.2: Application usage overview. The application has been deployed
since the week of March 16,
2020. This figure shows
the number of employees
and patients newly added
for tracking by the application each week between the
week of March 16 and the
week of June 8, 2020.
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pact of COVID-19 at the Boston VA. It has informed our mitigation efforts, and
policy decisions on the necessary infrastructure for providing detailed reports for various stakeholders with quick turnaround. Our database contains essential COVID-19
information on patients and employees such as clinical symptoms, known exposures,
testing history, testing locations, hospitalizations and death, current patient locations,
and quarantined employees. We have begun to use this data to develop aggregate
and patient-level reports to support the VA’s efforts in identifying new cases, contact
tracing, outbreak investigations, and employee workforce management.
On the one hand, the primary limitation of the platform is lack of full integration
with the EHR, which necessitates a workaround to address data latency. On the
other hand, this lack of integration substantially increases the generalizability of the
system to other healthcare systems, as COVIDDMP can be used in any healthcare
system after an appropriate script is written to provide input data in the expected
format. Further development in FileMan to automate the frequency of data extract
will allow additional latency reduction.

4.7

Conclusion

We have developed an informatics solution that facilitates communication and workflow across multiple disciplines to manage hospital employees possibly impacted by the
COVID-19 pandemic. Our solution is adaptable to evolving policies and procedures
for protecting healthcare personnel as the pandemic progresses, and it is available as
open-source software for use by other healthcare systems.
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Chapter 5
Sentiment analysis of medical record
notes for lung cancer patients at
the Department of Veterans Affairs
This Chapter is derived from Elbers et al. (Elbers et al., 2022)
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5.1

Abstract

Natural language processing of medical records offers tremendous potential to improve
the patient experience. Sentiment analysis of clinical notes has been performed with
mixed results, often highlighting the issue that dictionary ratings are not domain
specific. Here, for the first time, we re-calibrate the labMT sentiment dictionary
on 3.5M clinical notes describing 10,000 patients diagnosed with lung cancer at the
Department of Veterans Affairs. The sentiment score of notes was calculated for
two years after date of diagnosis and evaluated against a lab test (platelet count)
and a combination of data points (treatments). We found that the oncology specific
labMT dictionary, after re-calibration for the clinical oncology domain, produces a
promising signal in notes that can be detected based on a comparative analysis to
the aforementioned parameters.

5.2

Introduction

Estimating the sentiment expressed by text corpora has become popular in the social
sciences, especially with the increasing prevalence of social media platforms such as
Twitter and Facebook. The Hedonometer, developed by Dodds and Danforth(Dodds
& Danforth, 2010)(Dodds et al., 2011), estimates daily global happiness based on
Twitter messages (Dodds & Danforth, n.d.), and has been shown to reflect collective attention to global events. The instrument has been successfully utilized in a
wide range of domains from quantifying happiness in green spaces (Schwartz, Dodds,
O’Neil-Dunne, Danforth, & Ricketts, 2019) to identifying story arcs in palliative
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care conversations (Ross et al., 2020) and from understanding social amplification
(Alshaabi et al., 2021) to presidential engagement(Minot, Arnold, Alshaabi, Danforth, & Dodds, 2021).
Here, for the first time, we explore the possibility of re-calibrating the Hedonometer sentiment scoring instrument to the clinical oncology domain and utilizing it to
identify aspects of the patient trajectory through clinical notes. The resulting signal
could be promising as a non-invasive, real-time lens into systems of care, through
the interaction between the patient, provider and the healthcare system, making use
of all notes entered into the Electronic Health Care Records (EHR). Understanding
how care plans and communication are perceived by patients is crucial for continuous
improvement of healthcare systems and are currently often quantified only through
narrative or survey based studies(Jha, Orav, Zheng, & Epstein, 2008)(Broadbent et
al., 2015)(Ruiz-Ceamanos, Spence, & Navarra, 2022).
Sentiment scoring has been explored in the healthcare domain with mixed results.
For example, Weismann et al. explored several sentiment scoring methodologies on
notes recorded in the ICU (Weissman, Ungar, Harhay, Courtright, & Halpern, 2019)
and made available through the MIMIC-III data set(Johnson et al., 2016). They
found high variability between methods, but point out a strong association between
sentiment and death, that had been seen previously (Waudby-Smith, Tran, Dubin,
& Lee, 2018). Weisman et al. suggest that sentiment scoring methodology needs to
be more strongly tailored to the healthcare domain and addressed with coverage of
specific medical terminology. This argument was highlighted as well by McCoy et al.
(McCoy et al., 2015), who performed sentiment scoring on clinical notes utilizing a
generic vocabulary scored for polarity (negative vs positive).
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We agree that the sentiment associated with medical vocabulary differs greatly
from its more common layperson usage, and thus our first step in the present study
is to tailor a sentiment dictionary to the oncology domain. For example, the words
‘positive’ and ‘negative’ have a very different meaning in a clinical context then they
do in generic use. A ‘positive’ clinical test often signifies an diagnostic indication of
a health issue and is almost never a good event in medicine. In this manuscript, we
propose and execute a data-driven approach to re-calibration of the original labMT
sentiment dictionary, assisted by Subject Matter Experts (SME’s) each with 15+
years of experience working in clinical oncology. To foster future research in this area,
the re-calibrated score list is made openly available along with this study. Secondly,
we evaluated the domain-specific Hedonometer against different oncologic treatments
and platelet count lab results. This specific set of parameters was chosen to assess the
performance of the Hedonometer, since they are either very objective and often performed, such as the laboratory results known to be indicative of a patient’s well being
and cancer prognosis (platelet counts)(Sylman et al., 2018)(Zhang, Lv, Yu, & Zhu,
2017)(Maraz et al., 2013), or a combination of medication and date associations that
allow for comparison (treatments)(Howlader et al., 2020)(Nabi & Trinh, 2019)(Portier
et al., 2013). Our goal is to gauge if the Hedonometer, after re-calibration, can detect
a signal indicating clinical trajectory of cancer care using medical record notes.
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5.3
5.3.1

Methods
Selected Data

The cohort used in this analysis consists of 10,000 randomly selected patients from the
Department of Veterans’ Affairs (VA) diagnosed with lung cancer between 2017 and
2019. All notes (3,500,000+) were extracted from the VA’s Corporate Data Warehouse (CDW) from date of diagnosis till 2 years after. This resulted in a mean of 886
notes per patient per year and a standard deviation of 2180. To properly validate the
signal strength, if detecting any, of the re-calibration of the Hedonometer instrument
no sub-selection was made based on note types, i.e. all notes were included.

5.3.2

Re-calibration of the Hedonometer

First, we aimed to revise the LabMT word list for this clinical context, specifically
so the sentiment scores were oriented towards the cancer domain. The original study
produced the Language Assessment by Mechanical Turk sentiment ratings using an
online survey on Amazon’s crowdsourced work platform. For the present study, we
asked 5 health care providers (3 MDs, 2 nurses) with 10+ years experience in oncology
to (re)assess 200 high-importance words (details on their selection will be provided
later). In accordance with the original LabMT word list, words are scored on a
scale from 1 - 9, with 9 being the happiest or most positive value and 1 being the
least positive or most unhappy value. The instructions given to the SME’s were the
following:
‘The results of this survey will be used to measure the happiness of words in the
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context of lung oncology care notes. The overall aim is to asses how providers feel
about individual words in their clinical context. Please rate the following individual
words on a 9 point âunhappy - happyâ scale with 5 being neutral. 1. Read the word. 2.
Observe your emotional response. 3. Select score in accordance with your emotional
response’.
SME’s were able to select a radio button response for each word, with a reminder
of score meaning at 1 (’unhappy’), 5 (’neutral’), 9 (’happy’).
After exclusion of stop words (Wilbur & Sirotkin, 1992), the list of high-importance
words for domain specific re-scoring was selected as follows. We aimed to use both (a)
word frequency and (b) the likely difference between layperson and clinical context
to identify labMT words most mismatched in sentiment. We chose 100,000 random
notes from the larger dataset, and used these notes to design two distinct mechanisms
for re-evaluation.
First, we counted all non-labMT words in the notes, and sorted them by frequency.
The top 5 words in this lists were ‘tab’, ‘medication’, ’prn’, ’reviewed’ and ’provider’.
Second, we parsed the notes for appearances of each anchor labMT word wi , with
labMT sentiment hi , and identified the adjacent 5 words before and after in the notes.
The average sentiment of these neighboring words across all notes was calculated to
be hamb
, the so-called ambient sentiment, and compared with the original labMT
i
rating hi . Words wi were then sorted by the magnitude of hδi = |hi − hamb
| such that
i
outliers for which the medical context sentiment hamb
deviated substantially from
i
the context independent sentiment hi could be identified. Words not scored in the
original labMT study such as ‘medication’, found through frequency ranking, were
artificially assigned an hδi of 1. To combine these two word lists, we multiplied each
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word’s frequency in the notes by hδi , and truncated after the top 200. The resulting
200 words were deemed most important to re-evaluate, given their prominence in the
medical notes and their absent or poor context matching in labMT. Among the 200
words to be scored, a total of 66 new medical domain words were identified, and 134
labMT words were re-scored.

5.3.3

Calculating Sentiment

Sentiment for each note is calculated using the re-calibrated Hedonometer score list,
which includes the original words, the original words with new scores, and the new
words. In order to focus on the more informative sentiment contributions, words
with values between 4 and 6 in the original word list (Dodds et al., 2011) have
been excluded from calculating a note’s score. Due to the domain specific focus,
words scored by the SME’s have been included, regardless of score. A note’s score
is subsequently calculated by, after excluding stop words (Wilbur & Sirotkin, 1992),
obtaining the frequency of the unique words occurring in the note, looking up their
score in the re-calibrated word list, and multiplying the frequency of the word by its
score. After which the sum is taken and the mean for the individual note is calculated
(Dodds et al., 2011). Words that are not scored are ignored in all calculations and in
line with the Hedonometer strategy no further word cleaning, such as stemming, is
performed(Dodds et al., 2011).
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Data Type
Start
End
Iteration
Notes
Date of Diagnosis
Date of Diagnosis + 24 months
all
Treatment
Start of Treatment
Start of Treatment + 6 weeks
daily
Platelet Count Day of Test - 1 week
Day of Test + 1 week
all
Table 5.1: Data Collection

5.3.4

Comparative Analysis

In order to validate the calibration of the Hedonometer instrument, several external
parameters were selected to detect a signal in notes. Parameters that were selected for
comparison included objective data in the form of lab test outcomes; platelet count,
and a combination parameter based on medications, see table 5.1.

Platelet Count
Platelet count was selected as an objective or hard measure, since it has been shown
to be an indicator of how well a patient is feeling and has been linked extensively
to cancer(Sylman et al., 2018)(Zhang et al., 2017)(Maraz et al., 2013). Additionally,
this lab test is ordered quite often, especially in cancer care, varying from every two
weeks to daily depending on a patient’s state. Since platelet count lab test outcomes
come in a multitude of units, data was cleaned up and converted to one unit type
(109 /L) before inclusion. For this analysis, platelet count results were divided into
three groups: low, normal and high. A low platelet count means below the threshold
of 160 109 /L, a normal platelet count is between 160 109 /L and 410 109 /L, and a high
platelet count above 410 109 /L. All clinical notes one week before and one week after
a platelet count test was performed were selected and individually scored. These notes
were placed in the group in accordance with the lab test outcome. The three groups
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were subsequently tested for normality with Shapiro’s as well as Anderson’s tests. The
outcome of these tests determines whether a one-way ANOVA or Kruskal-Wallis test
is most appropriate to assess significance. If a significant difference between groups is
found, a post-hoc test in the form of Tukey (parametric) or Conover (non-parametric)
will be performed to find out which specific between-strata comparisons of platelet
count appear to account for the overall difference in sentiment.

Treatments
As a combined data point to validate the re-calibrated Hedonometer against, cancer
treatments were chosen. Specifically, chemotherapy, platinum (a form of chemotherapy), targeted and checkpoint therapies were evaluated. First, 39 medications were
mapped to the treatments (see table 5.6 in the Appendix), subsequently all these
medications and the start of treatment were pulled from the Inpatient, Outpatient,
Pharmacy and IV domains in VA’s Corporate Data Warehouse (CDW). As treatments might be given in combination or sequence, patients can be counted more then
once. Notes were analyzed until six weeks after the start of the specific medication
and associated with the treatment. The mean note score for each day was calculated,
and a visual inspection of the mean note score fluctuation over time was provided and
analyzed with SME’s in clinical oncology. Additionally, word shift graphs (Gallagher
et al., 2021) were created to gather understanding of which words influenced clear sentiment fluctuations. Lastly, the analysis was ran a second time, utilizing the LabMT
dictionary only, to evaluate the difference with the re-calibrated dictionary.
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5.4
5.4.1

Results
Re-calibration of the Hedonometer

Please see 5.8 Appendix for a complete list of the 200 words selected based on their
surrounding sentiment and frequency to be re-scored by SME’s. Figure 5.1 shows
that our selection of 200 words will cover 30% of note text.

Figure 5.1: Words are ranked based on the product of their clinical note coverage and the
difference in word score to a word’s ambient sentiment score.

Mean standard deviation of re-scoring the high-importance words between the
SME’s was 0.51 on the 9-point scale. The mean of re-scored words, 4.93, is lower
then the mean of the original labMT dataset, namely 5.37. Full scores and standard
deviation are available in table 5.4 in the Appendix. The addition and updates of
the oncology domain specific words result in a word list of 10,253, an increase of 66
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words from the original 10,187. Examination of the re-scored words, see figure 5.2a,
shows that word ‘positive’ is scored less high by the SME’s then in LabMT (5.6 vs.
7.8), while the word ‘negative’ is scored much higher (5.8 vs. 2.4). Other words
standing out include ‘discharge’, ‘pain’, ‘cancer’, ‘veteran’ and ‘family’. To compare,
figure 5.2b shows the top 50 words with the largest shifts in word score for both the
SME’s evaluation and based on the surrounding sentiment calculation. A subset of
random clinical notes was evaluated for confirmatory no’s; standard questions generally answered with the word ’no’. Questions similar to ’have you recently travelled
outside of the country?’, with answers of ‘no’ were identified, however did not occur in
high frequency. It appears that repetitive questions are often answered with the word
’negative’, e.g. ’negative for fever, chills, blurring of vision, redness of eye, nausea’ a
word that was re-scaled by the SME’s. The word ’no’ itself is ranked 410, and was
thus not highly influential on score calculation.

5.4.2

Comparative Analysis

Platelet Count
Every group with platelet count results, low, normal and high, was comprised evenly
to contain 39882 unique notes. This number was equivalent to the group with the lowest count of notes (high group), for the larger groups a random subset was selected to
create equal groups. All three groups failed both the Shapiro and Anderson normality
tests. Although visual inspection of QQ-plots in addition to histograms did appear
to come close to normality, the high number of samples might have played a factor in
failing the tests. To be on the safe side, it was decided to test non-parametric, thus
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(a) LabMT vs SME word scores

(b) Top 50 largest word shifts changes in
respect to LabMT

Figure 5.2: Word score shifts due to calibration by SME’s. Figure 5.2a on the left compares
the LabMT scores to the scores assigned by the SME’s. The right figure 5.2b compares the
ambient sentiment for each anchor term and the eventual assessment by the SME’s.
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a Kruskal-Wallis was subsequently performed. The result of the Kruskal-Wallis test
showed a significant difference (p = 2.79 × 10−06 ) and post-hoc Conover results are
displayed in table 5.2.
High
High
1
Low
0.56
Normal 3.49e−06

Low
0.56
1
4.84e−05

Normal
3.49e−06
4.84e−05
1

Table 5.2: Platelet Count - Post Hoc Conover Test

A significant difference in note score is present between the high platelet count
group and the normal platelet count group, as well as between the low platelet count
group and the normal platelet count group. However no difference was found between
the high and low platelet count group. The high platelet count group had a median
note score of 5.308; mean of 5.355, the low platelet count group a median note score
of 5.316; mean of 5.356, while the normal platelet count group had a slightly higher
median note score of 5.325; mean of 5.363.

Treatments
Evaluating the scoring of daily notes generated during the six weeks after the start
of either one of the four different treatments; chemotherapy (633160 notes), platinum
(317392 notes), checkpoint (230500 notes) and targeted (139908 notes), shows a cyclical weekly pattern, see figure 5.3. Day 40 for targeted therapy has the lowest count
of data points, namely 1980 notes.
According to SME’s in clinical lung cancer, this cyclical pattern can be explained
due to patients’ weekly visits with their providers at which point they are asked
about side-effects, bringing down the sentiment score of generated notes. Day 21
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Figure 5.3: Note scores on a day to day basis per treatment arm, starting at the day of
treatment till six weeks from date of start of treatment.

after treatment is known to be related to the worst side effects, after which side
effects begin improving. Targeted therapy tends to produce fewer side-effects and
is often given to patients in better health, which could explain the better overall
score and reduced fluctuation. However, targeted therapy still appears to also follow
the cyclical pattern present in the other three treatments. Reasons behind checkpoint
therapy having the deepest dip in sentiment score, as opposed to chemotherapy, could
not be identified by our SME’s.
To better identify what creates the dip in note scores on day 21, word shift plots
are created, see figure 5.4. Words related to lung cancer treatment such as ‘lung’,
‘cancer’, ‘treatment’, ‘dose’, ‘mouth’ and ‘chemotherapy’ appear to drive the score
down. While more generic words, such as ‘care’, ‘support’, ‘activity’, ‘patient’ and
‘independent’, related to patient care seem to positively influence the note scores on
peak days. Notably the text size is larger on day 21, associating more volume of note
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(a) Checkpoint therapy arm

(b) Chemotherapy arm

Figure 5.4: Using notes authored on Day 21 of treatment as a reference, word-shift graphs
detail the words influencing the drop in sentiment when compared with day 19 (left) and
and 17 (right). Looking at the comparison between days 19 and 21 on the left, words
appearing on the left side of the graph contribute positively to day 21, while words on the
right side contribute positively to day 19 (there are many more of this type). For example,
the relatively positive words ‘support’, ‘discharge’, and ‘independent’ are more common on
day 19. The relatively negative words ‘disease’ and ‘metastatic’ are less common on day 19.
Going against the overall trend, the relatively positive words ‘today’, ‘well’, and ‘stable’ are
more common on day 21. The relatively negative words ‘risk’, ‘pressure’, and ‘fall’ are less
common on day 21.
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generation during visits. Rerunning the analysis with the original LabMT dictionary
showed a similar cyclical pattern, however the overall note scores were 0.3 points
higher. This difference was attributed to the prevalence of missing clinical words in
LabMT, which were generally scored low by the SME’s.

5.5

Discussion

We have designed and implemented a data-driven method for re-calibration of an
existing sentiment scoring instrument, the Hedonometer, in a specific healthcare domain. This re-calibration has been proposed numerous times in previous research on
sentiment in clinical notes (Weissman et al., 2019)(Waudby-Smith et al., 2018)(McCoy
et al., 2015) as a solution to the mixed results found when utilizing existing vocabularies in this context. However, to the authors’ awareness, re-calibration has not
been done before. The re-calibration of the labMT sentiment dictionary for the oncology healthcare domain resulted in 200 re-scored words, which together cover 30%
of clinical note text for the oncology domain.
The successful application of the domain-specific Hedonometer in our comparative
analysis suggests that a signal is present and measurable in clinical notes. Validating the instrument on laboratory test outcomes, we found a significant difference in
normal versus low or high platelet counts. Additionally, a consistent cyclic effect
is visible when scoring notes in relation to cancer treatment timelines, showing a
comparable cycle for all treatments. This cycle can be explained by weekly provider
visits discussing side effects and treatment itself, with a clear dip on day 21 for the
chemotherapy (incl. platinum) and checkpoint treatments indicating the side-effects
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being at their worst. Discussion with clinical SME’s underscores this belief. When
examining score shift with day 21, treatment related words indeed appear to drive
the note score down. This negative shift is also consistent with Portier et al. (Portier
et al., 2013), who perform sentiment analysis on online cancer support forums and
find that side-effects of treatments are a topic with a clear negative sentiment shift.
Though an explanation for the low dip in checkpoint treatment specifically was not
presented by the SME’s, it can be hypothesized that this treatment often includes
further advanced cancer cases or cases in palliative care. It would be interesting to
see if splitting out durvalumab, often given to less advanced cases, would generate
higher sentiment.
Our evaluation of the domain-specific Hedonometer is far from exhaustive, and
future research should be done to understand better how and where the instrument
can be utilized and what its limitations are in the oncology and healthcare domain.
The finding that a signal appears present, detectable, and consistent is encouraging
and the authors hypothesize next research steps as stratification of the cohort and
researching difference between note types, both of which have not been addressed
here, and evaluation against other parameters. Other parameters could include, for
example, the the VA - Frailty Index(Cheng et al., 2021)(DuMontier et al., 2021), a
well-validated performance measurement based on a large set of variables across different healthcare domains, or the VA-CAN score(Osborne, Veigulis, Arreola, Roosli,
& Curtin, 2020), surgery or neutrophil counts. If the signal remains robust, clinical
and research implementation can vary from quality control of a new medication or
treatment plan, to better understanding certain subgroups to quantifying differences
between hospital, provider and nurse care.
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5.7

Data Availability

Patient related and note data cannot be shared publicly because it involves sensitive
human subject data. Data may be available for researchers who meet the criteria
for access to confidential data after evaluation from VA Research and Development
Committees. As a VA national legal policy (VHA Directive 1605.01), VA will only
share patient data if there is a fully executed contract in place for the specific project.
A common contractual mechanism utilized for this type of sharing is a ’Cooperative
Research and Development’ (CRADA) agreement. These contracts are typically negotiated in collaboration with VA national Office of General Council (OGC) and lawyers
from the collaborating institution. These national sharing policies and standards also
apply to deidentified data. In addition, if a contract is in place allowing sharing of
deidentified data outside of VA, then VA national policy (VHA Directive 1605.01),
states that deidentification certification needs to be met by Expert Determination.
The expert determination requires independent assessment from an experienced master or PhD in biostatistics, from a third party not involved in the project, and may
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require outside funding to support. In addition, for an outside entity to preform research on VA patient data, IRB as well as VA Research and Development Committee
approval is required for the specific project. Data requests may be sent to: VA Information Resource Center (VIReC) Building 18 Hines VA Hospital (151V) 5000 S. 5th
Avenue Hines, IL 60141-3030 708-202-2413 708-202-2415 (fax) virec@va.gov.
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rnk
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40

word
patient
tab
take
lung
tablet
medications
non
one
history
pulse
discharge
mouth
chest
left
medication
treatment
score
scale
active
assessment
clinic
yes
heart
daily
prn
lower
signs
screen
new
stage
reviewed
provider
denies
refills
chronic
staff
bed
veteran
every
days
right

coverage
0.016321
0.006045
0.006038
0.003023
0.003708
0.004553
0.00275
0.005072
0.002204
0.001321
0.001599
0.006201
0.00215
0.003353
0.002824
0.002768
0.001502
0.001412
0.011381
0.003469
0.001325
0.003985
0.001277
0.002788
0.001711
0.001281
0.001072
0.000641
0.001461
0.000748
0.001555
0.00151
0.001481
0.001473
0.000946
0.001169
0.002312
0.003716
0.003759
0.002686
0.003551
85

diff.
0.488
1
0.886
1.574
1.264
1
1.566
0.791
1.607
2.347
1.879
0.478
1.343
0.844
1
0.919
1.635
1.558
0.192
0.568
1.425
0.464
1.412
0.646
1
1.315
1.533
2.553
1.115
2.137
1
1
1
1
1.531
1.231
0.614
0.37
0.365
0.51
0.384

diff x cov
0.007959
0.006045
0.005348
0.004757
0.004687
0.004553
0.004305
0.00401
0.003542
0.003101
0.003004
0.002964
0.002887
0.002829
0.002824
0.002544
0.002455
0.002201
0.002186
0.00197
0.001889
0.001847
0.001804
0.0018
0.001711
0.001685
0.001643
0.001636
0.001629
0.001598
0.001555
0.00151
0.001481
0.001473
0.001448
0.001438
0.001419
0.001376
0.001373
0.001371
0.001365

Table 5.3: Top 40 words based on rank of Surrounding Sentiment ∗ Text Coverage

Words
patient
tab
take
lung
tablet
medications
non
one
history
pulse
discharge
mouth
chest
left
medication
treatment
score
scale
active
assessment
clinic
yes
heart
daily
prn
lower
signs
screen
new
stage
reviewed
provider
denies
refills
chronic
staff
bed
veteran
every
days

Score
6
5
5.2
5
5
4.6
4.8
5
4.8
5.4
7.2
5
5
5
4.8
5
5
5
5.6
5.6
5.4
6.2
5.6
5
5
5
5
5
5.4
4.8
5.2
5.4
4.2
5.2
4.2
5
5
6
5
5

SD
2
0
0.4
0
0
0.49
0.4
0
0.4
0.8
0.98
0
0
0
0.4
0.63
0
0
0.8
1.2
0.8
1.6
1.2
0
0
0
0
0
1.02
1.6
0.4
0.49
0.75
0.4
0.98
0
0
2
0
0

Words
oral
hcl
qty
intake
mobility
respiratory
back
icd
mild
inj
inhl
day
dressing
medical
imaging
allergies
sct
intact
use
diet
inpatient
per
reports
labs
last
questions
chemotherapy
twice
units
cancer
family
soln
orders
edema
breath
required
positive
goal
number
released

Score
5
4.6
5
5
5.2
5
5
4.6
5.4
4.8
5
5
5
5
5
5
4.6
6
5
4.6
3.6
5
5
5
5
5.8
4.4
5
5
3.6
6
5
5
3.8
5
4.6
5.6
6.2
5
5.4

SD
0
0.8
0
0
0.4
0
0
0.8
0.49
0.4
0
0
0
0
0
1.26
0.8
1.26
0
0.8
1.36
0
0
0
0
1.17
0.8
0
0
1.5
1.26
0
0
1.17
0
0.8
0.8
0.75
0
0.8

Words
ulcer
note
albuterol
past
biopsy
concerns
catheter
precautions
sodium
bilateral
oncology
increase
home
transfer
date
neck
expiration
free
vital
ref
post
screening
evidence
limited
minutes
inhale
need
expr
secondary
copd
adl
brain
prior
issu
verified
clinical
abdomen
male
scan
call
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Table 5.4: Re-scoring outcomes
from SME’s, part 1

Score
3.6
5
4.2
5
3.2
3
5
5.2
5
5
3.4
4.4
5.4
4.6
5
5
4.4
6.2
5.2
4.8
5
5
5
5.4
5
5.4
5
4.6
4.5
3.8
5.8
4.6
4.6
4.4
4.8
4.8
5
5.4
5
5

SD
1.02
0
0.98
0
1.47
1.26
0
0.4
0
0
1.36
1.2
0.49
0.8
0
0
1.2
1.17
0.4
0.4
0
0
0
0.8
0
0.8
0
0.8
0.87
1.17
0.98
1.96
0.49
0.8
0.4
0.4
0
0.8
0
0

Words
right
procedure
outpatient
lobe
pain
skin
dry
high
related
needs
test
cap
dose
interventions
sig
half
present
nutrition
location
current
blood
cell
normal
bowel
fall
instructions
bid

Score
5
5
4.8
5.2
3.6
5
4.6
5
5
5
4.6
5
5
5
4.8
5
4.6
5.6
5
5
5
5
6.4
5
4
5
5

SD
0
0
0.4
0.98
2.15
0
0.8
0
0
0
0.8
0
0
0
0.4
0
0.8
0.8
1.67
0
0
0
1.5
0
0.89
0
0

Words
alcohol
lock
recent
unit
report
lymph
weight
occur
months
caregiver
level
well
capsule
exam
moisture
consult
needed
shift
output
tablets
may
name
glucose
pending
nausea
chloride
four

Score
5.4
4.6
5
5
5
5.2
5.2
5
5
6.6
5
6.6
5
5
5
4.8
5
5
5
5
5
5
5.2
3.8
3.4
5
4.8

SD
1.02
0.8
0
0
0
0.4
1.6
0
0
1.02
0
1.36
0
0
0
0.4
0
0
0
0
0
0
0.4
1.6
1.36
0
0.4

Words
within
carcinoma
nodule
year
two
ordered
assistance
prevention
negative
rate
puffs
low
room
findings
moderate
person
constipation
mmol
wbc
care
multiple
extremities
shortness
results
metastatic
meals

Table 5.5: Re-scoring outcomes from SME’s, part 2
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Score
4.4
2.6
3.8
5
5
5
4.4
6.2
5.8
5
4.4
4.4
5
5
4.6
5.4
2.8
5
5
5.4
4.2
5
4
5.4
2.8
5.6

SD
1.2
1.62
1.47
0
0
0
0.8
1.17
1.6
0
1.2
1.2
0
0
0.8
0.8
1.83
0
0
0.8
1.6
0
1.26
0.8
1.6
0.8

Generic
abraxane
afatinib
alectinib
atezolizumab
bevacizumab
brigatinib
capmatinib
carboplatin
ceritinib
cisplatin
crizotinib
dabrafenib
dacomitinib
docetaxel
doxorubicin
durvalumab
entrectinib
erlotinib
etoposide
etoposide
everolimus
gefitinib
gemcitabine
ipilimumab
larotrectinib
lorlatinib
mechlorethamine
necitumumab
nivolumab
osimertinib
paclitaxel
pembrolizumab
pemetrexed
ramucirumab
selpercatinib
topotecan
trametinib
vinorelbine

category
chemotherapy
targeted
targeted
checkpoint
targeted
targeted
targeted
platinum
targeted
platinum
targeted
targeted
targeted
chemotherapy
chemotherapy
checkpoint
targeted
targeted
chemotherapy
chemotherapy
targeted
targeted
chemotherapy
checkpoint
targeted
targeted
chemotherapy
targeted
checkpoint
targeted
chemotherapy
checkpoint
chemotherapy
targeted
targeted
chemotherapy
targeted
chemotherapy

Brand
gilotrif
alecensa
tecentriq
avastin
alunbrig

zykadia
xalkori
tafinlar
vizimpro
taxotere
adriamycin
imfinzi

etopophos
afinitor
iressa
gemzar
yervoy
vitrakvi
lorbrena
mustargen
portrazza
opdivo
tagrisso
taxol
keytruda
alimta
cyramza
hycamtin
mekinist
navelbine

Table 5.6: Medication treatment matrix
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